Eidos, a medication targeting amyloid transthyretin cardiomyopathy (ATTR-cm) that causes heart failure in adults, came to us to design an informative website to communicate ATTR-cm complexities to patients. We also designed print materials and a conventional booth for Eidos’ debut in 2020.